| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $0.69 | - | - |
| Q1'26 | $0.55 | $0.61 | +11.6% |
| Q4'25 | $0.52 | $0.58 | +11.1% |
| Q4'24 | $0.26 | $0.37 | +42.8% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $368M | - | - |
| Q1'26 | $298M | $308M | +3.5% |
| Q4'25 | $260M | $271M | +4.0% |
| Q4'24 | - | $141M | - |
Market Data
ALAB is currently trading at $412.88, giving Astera Labs, Inc. a market cap of 70.79B and a P/E ratio of 264.5. Today's range spans $401.62–$424.33, with shares opening at $409.38 and moving up $0.10 (0.0%) from the prior close. DailyIQ's technical score sits at 77/100 (BUY) with a news sentiment reading of 52/100.
Over the past year ALAB has traded between $88.19 and $499.48 - the current price is +368.2% off the 52-week low and -17.3% from the high. 32 analysts cover the stock with a Buy consensus and a mean 12-month target of $272.47 (range $155.00–$460.00), implying downside of -34.0%.
Astera Labs, Inc. (ALAB) is a large-cap in Technology with 70.79B in market cap, and the current setup is one of the cleaner bullish reads in the space. Technical score: 77/100 (BUY). Sentiment: neutral at 52/100. Price: $412.88 (in the upper portion of its 52-week range). The current P/E ratio stands at 264.5. The 52-week range of $88.19–$499.48 provides structural context - and the current technical/sentiment alignment is the type of setup that attracts both momentum and growth-oriented capital.
Earnings revision cycles in large-cap Technology names tend to compound: when technicals confirm a BUY thesis (77/100) and news sentiment (52/100, neutral) supports the narrative, analyst upgrades follow price rather than lead it. At $412.88 (in the upper portion of its 52-week range), ALAB's position within the $88.19–$499.48 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).